A new analytical platform reveals signature changes in immune cells of the brain during aging and neurodegenerative conditions such as Alzheimer’s disease.
By selectively switching on neurons with light, scientists can piece together crucial events in Alzheimer’s disease progression.
A large-scale genome study suggests that Alzheimer’s and an eye disorder called glaucoma share a common disease development pathway.
Single-cell genomic technology is providing fresh perspectives on the origins of microglia, ancient immune sentinels found in the brain.
Researchers at A*STAR are growing better models of aging brain diseases in the search to stop the decline
Fluorescent probe selectively detects biomarkers linked to Alzheimer’s disease